{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:28:25Z","timestamp":1770143305836,"version":"3.49.0"},"reference-count":96,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dual Diagnosis"],"published-print":{"date-parts":[[2025,7,3]]},"DOI":"10.1080\/15504263.2025.2515018","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:31:34Z","timestamp":1750217494000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["A Meta-Analysis on the Effect of Depression on Adherence to Medication for Opioid Use Disorder"],"prefix":"10.1080","volume":"21","author":[{"given":"Taylor R.","family":"Fox","sequence":"first","affiliation":[{"name":"Department of Psychology, Indiana University Indianapolis","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna C. S.","family":"Garrison","sequence":"additional","affiliation":[{"name":"Department of Psychology, Indiana University Indianapolis","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle S.","family":"Minor","sequence":"additional","affiliation":[{"name":"Department of Psychology, Indiana University Indianapolis","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse C.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Psychology, Indiana University Indianapolis","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Cyders","sequence":"additional","affiliation":[{"name":"Department of Psychology, Indiana University Indianapolis","place":["Indianapolis, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/17405629.2014.963549"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7549.1080"},{"key":"e_1_3_3_5_1","unstructured":"American Society of Addiction Medicine. (2023). https:\/\/www.asam.org\/advocacy\/practice-resources\/regulatory-resources\/select-federal-policies-addiction-medications#:\u223c:text=Dispensing%20of%20Methadone%20To%20Relieve Addiction%20Act%20(the%20Act)"},{"key":"e_1_3_3_6_1","volume-title":"Opioid addiction - Statpearls - NCBI bookshelf","author":"Azadfard M.","year":"2022","unstructured":"Azadfard, M., Huecker, M. R., & Leaming, J. M. (2022). Opioid addiction - Statpearls - NCBI bookshelf. Opioid Addiction. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448203\/"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108494"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.06.020"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1081"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-022-00299-1"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33078-2"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S85667"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.10.3.276"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100102"},{"issue":"3","key":"e_1_3_3_15_1","first-page":"791","article-title":"Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs","volume":"34","author":"Broome K. M.","year":"1999","unstructured":"Broome, K. M., Flynn, P. M., & Simpson, D. D. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34(3), 791\u2013806.","journal-title":"Health Services Research"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v64n0213"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd016-0029"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.7.756"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.17545"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.019"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.10.63"},{"key":"e_1_3_3_22_1","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen J.","year":"1988","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Lawrence Erlbaum Associates.","edition":"2"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00095-0"},{"issue":"1","key":"e_1_3_3_24_1","first-page":"13","article-title":"SCL-90: An outpatient psychiatric rating scale\u2013preliminary report","volume":"9","author":"Derogatis L. R.","year":"1973","unstructured":"Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale\u2013preliminary report. Psychopharmacology Bulletin, 9(1), 13\u201328.","journal-title":"Psychopharmacology Bulletin"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000114908.90348.f9"},{"key":"e_1_3_3_26_1","volume-title":"StatPearls","author":"Durrani M.","year":"2024","unstructured":"Durrani, M., & Bansal, K. (2024). Methadone. In StatPearls. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562216\/"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01352-y"},{"key":"e_1_3_3_28_1","unstructured":"Federal Register. (2023). Expansion of induction of buprenorphine via telemedicine encounter. https:\/\/www.federalregister.gov\/ documents\/2023\/03\/01\/2023-04217\/expansion-of-induction- of-buprenorphine-via-telemedicineencounter"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44159-022-00050-2"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1037\/pas0000275"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000088"},{"issue":"2","key":"e_1_3_3_32_1","first-page":"126","article-title":"Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic","volume":"43","author":"Gelkopf M.","year":"2006","unstructured":"Gelkopf, M., Weizman, T., Melamed, Y., Adelson, M., & Bleich, A. (2006). Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. The Israel Journal of Psychiatry and Related Sciences, 43(2), 126\u2013136.","journal-title":"The Israel Journal of Psychiatry and Related Sciences"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199802000-00009"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.017"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2020.1726549"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz249"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S127277"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2019.04.011"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108447"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1704-y"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106325"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.3.4.486"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720932017"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20843"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2011.38"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.1982"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2015.03.020"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00592"},{"issue":"8","key":"e_1_3_3_49_1","first-page":"18861","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp J. F.","year":"2015","unstructured":"Karp, J. F., Butters, M. A., Begley, A. E., Miller, M. D., Lenze, E. J., Blumberger, D. M., \u2026 & Reynolds, C. F. (2015). Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. The Journal of Clinical Psychiatry, 75(8), 18861.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2016.1197231"},{"key":"e_1_3_3_51_1","unstructured":"Li X. (2021). Determine the relationship between nonmedical opioid use and mental functioning [Doctoral dissertation]. Saint Louis University."},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.9.2154"},{"key":"e_1_3_3_53_1","volume-title":"Practical meta-analysis","author":"Lipsey M. W.","year":"2001","unstructured":"Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis. Sage."},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0094-5"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108399"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17282"},{"key":"e_1_3_3_57_1","first-page":"27","article-title":"GPs office-based methadone maintenance treatment in Trieste, Italy therapeutic efficacy and predictors of clinical response","volume":"10","author":"Michelazzi A.","year":"2008","unstructured":"Michelazzi, A., Vecchiet, F., Leprini, R., Popovic, D., Deltito, J., & Maremmani, I. (2008). GPs office-based methadone maintenance treatment in Trieste, Italy therapeutic efficacy and predictors of clinical response. Heroin Addiction and Related Clinical Problems, 10, 27\u201338.","journal-title":"Heroin Addiction and Related Clinical Problems,"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01599-3"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12896"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29676"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.21m14140"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2425"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-022-00246-5"},{"key":"e_1_3_3_64_1","unstructured":"National Institute on Drug Abuse (NIDA). (2021). How much does opioid treatment cost? https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/how-much-does-opioid-treatment-cost"},{"key":"e_1_3_3_65_1","unstructured":"National Institute on Drug Abuse (NIDA). (2023). Drug overdose death rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_3_3_66_1","unstructured":"National Institute on Drug Abuse (NIDA). (2024). Medications to treat opioid use disorder research report. https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/efficacy-medications-opioid-use-disorder"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.12.085"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.004982012"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.06.024"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1151\/spp053113"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2023.02.016"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00686.x"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-7-22"},{"key":"e_1_3_3_74_1","unstructured":"Salloum I. Cornelius J. & Chakravorthy S. (2003). Utility of combined naltrexone valproate treatment in bipolar alcoholics: A randomized open-label pilot study. Papers 26th Annual Scientific Meeting of the Research Society on Alcoholism Ft. Lauderdale FL."},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000085417.08426.54"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.5.3.350"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1604339"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00272-4"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-1274-3"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1712277115"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720931261"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-26.7.675"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.01.015"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233977"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2011.00186.x"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2015.1023455"},{"key":"e_1_3_3_87_1","unstructured":"University of Arkansas for Medical Sciences (UAMS). (2023). https:\/\/psychiatry.uams.edu\/clinical-care\/cast\/what-is-vivitrol\/#:\u223c:text=Dosage%20and%20Administration&text=VIVITROL%20is%20available%20in%20one month%20by%20a%20healthcare%20provider"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01372-0"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004014"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxaa001"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D252"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00884.x"},{"key":"e_1_3_3_93_1","volume-title":"Comparative effectiveness review methods: Clinical heterogeneity","author":"West S. L.","year":"2010","unstructured":"West, S. L., Gartlehner, G., Mansfield, A. J., Poole, C., Tant, E., Lenfestey, N., Lux, L. J., Amoozegar, J., Morton, S. C., Carey, T. C., Viswanathan, M., & Lohr, K. N. (2010). Comparative effectiveness review methods: Clinical heterogeneity. Agency for Healthcare Research and Quality. (US)."},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2009.06.001"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178221816685087"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v19i8.30"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108996"}],"container-title":["Journal of Dual Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15504263.2025.2515018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:54:18Z","timestamp":1757699658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15504263.2025.2515018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7,3]]}},"alternative-id":["10.1080\/15504263.2025.2515018"],"URL":"https:\/\/doi.org\/10.1080\/15504263.2025.2515018","relation":{},"ISSN":["1550-4263","1550-4271"],"issn-type":[{"value":"1550-4263","type":"print"},{"value":"1550-4271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjdd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=wjdd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}